Discovery of (7-aryl-1,5-naphthyridin-2-yl)ureas as dual inhibitors of ERK2 and Aurora B kinases with antiproliferative activity against cancer cells
- 1 August 2014
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 24 (16) , 3748-3752
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Small‐Molecule Inhibitors of the ERK Signaling Pathway: Towards Novel Anticancer TherapeuticsChemMedChem, 2010
- Targeting cancer with small molecule kinase inhibitorsNature Reviews Cancer, 2009
- Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistanceBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancerOncogene, 2007
- Signaling Through RAS-RAF-MEK-ERK: from Basics to BedsideCurrent Medicinal Chemistry, 2007
- Mechanisms of drug inhibition of signalling moleculesNature, 2006
- Recent progress in targeting the Raf/MEK/ERK pathway with inhibitors in cancer drug discoveryCurrent Opinion in Pharmacology, 2005
- Protein kinases — the major drug targets of the twenty-first century?Nature Reviews Drug Discovery, 2002
- The Raf/MEK/ERK pathway: new concepts of activationBiology of the Cell, 2001
- MAP KinasesChemical Reviews, 2001